TB500 (Thymosin Beta) – 5mg

TB-500 (5mg) protocols focus on this synthetic version of a peptide fragment related to Thymosin Beta-4, a naturally occurring protein involved in tissue repair and cellular regeneration. TB-500 is studied for its potential role in supporting wound healing, reducing inflammation, and improving recovery in muscles, tendons, and connective tissue. This guide outlines a subcutaneous administration approach optimized for the 5 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical dosing range: 2–5 mg per week (often split into multiple injections)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the subcutaneous regimen.

  • Goal: Support tissue repair, inflammation control, and recovery
  • Schedule: 1–2 injections per week or split dosing across the week
  • Dose Range: 2–5 mg weekly total

Suggested approach for the 5 mg vial format.

  • Start: 2 mg per week (split into 2 injections if preferred)
  • Target: 2–5 mg per week, depending on recovery needs
  • Frequency: 1–2 times per week or divided into smaller doses every 2–3 days
  • Vial Duration: One 5 mg vial typically lasts 1–2 weeks, depending on dosing
  • Timing: Flexible; often administered near injury sites when applicable

TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide modeled after a naturally occurring protein found in nearly all human and animal cells. It plays a key role in actin regulation, which is essential for cell movement, tissue remodeling, and repair processes.

By promoting cell migration and angiogenesis (formation of new blood vessels), TB-500 may enhance the body’s natural healing response. It is also studied for its ability to reduce inflammation and support the regeneration of muscle, tendon, ligament, and soft tissue structures. These properties make it widely researched in recovery and injury-repair contexts.

Observations based on preclinical and early research.

Potential Benefits:

  • May support faster recovery from injury
  • May reduce inflammation in soft tissues
  • May improve flexibility and mobility
  • May enhance tissue repair and regeneration

Possible Side Effects:

  • Mild fatigue in some users
  • Temporary injection-site irritation
  • Headache or light dizziness in rare cases
  • Long-term human safety data are limited; it remains investigational